日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Trained Immunity Exacerbates Inflammatory Arthritis Progression via Promoting Synovial Fibroblast Ferroptotic Resistance.

训练免疫通过促进滑膜成纤维细胞铁凋亡抵抗加剧炎症性关节炎的进展。

Su Haibo, Zhang Baoying, Deng Qiudi, Huang Jiaxin, Feng Jinyu, Fu Yuan, Huang Yuejun, Deng Weikun, Su YingJun, Liu Huisheng, Shao Ning-Yi, Zhang Zhenhui, Dai Jianwei

TIME FOR COFFEE regulates phytochrome A-mediated hypocotyl growth through dawn-phased signaling

TIME FOR COFFEE 通过黎明阶段信号调节光敏色素 A 介导的下胚轴生长

Yan Wang, Chen Su, Yingjun Yu, Yuqing He, Hua Wei, Na Li, Hong Li, Jie Duan, Bin Li, Jigang Li, Seth J Davis, Lei Wang

Identifying changes in immune cells and constructing prognostic models using immune-related genes in post-burn immunosuppression

利用免疫相关基因识别烧伤后免疫抑制中免疫细胞的变化并构建预后模型

Wang, Peng; Zhang, Zexin; Yin, Bin; Li, Jiayuan; Xialin, Cheng; Lian, Wenqin; Su, Yingjun; Jia, Chiyu

Macrophages are necessary for skin regeneration during tissue expansion

巨噬细胞在组织扩张过程中对皮肤再生至关重要

Ding, Jianke; Lei, Lei; Liu, Shiqiang; Zhang, Yu; Yu, Zhou; Su, Yingjun; Ma, Xianjie

A Novel Supra-Brow Combined with Infra-Brow Lift Approach for Asian Women

一种针对亚洲女性的新型眉上提拉结合眉下提拉术

Shu, Maoguo; He, Lin; Su, Yingjun; Shi, Junli; Zhang, Xi; Liu, Xiangyu; Yu, Xueyuan

Chemokine Regulation of Neutrophil Infiltration of Skin Wounds

趋化因子对中性粒细胞浸润皮肤伤口的调控

Su, Yingjun; Richmond, Ann

Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group.

硼替佐米联合多柔比星治疗肝细胞癌的 II 期试验 (E6202):东部肿瘤协作组的一项试验

Ciombor Kristen K, Feng Yang, Benson Al Bowen 3rd, Su Yingjun, Horton Linda, Short Sarah P, Kauh John Sae Wook, Staley Charles, Mulcahy Mary, Powell Mark, Amiri Katayoun I, Richmond Ann, Berlin Jordan

The good and the bad of chemokines/chemokine receptors in melanoma

趋化因子/趋化因子受体在黑色素瘤中的利与弊

Richmond, Ann; Yang, Jinming; Su, Yingjun